Upper panel: The minimum-norm solution for the difference between the Grand Means of the tinnitus and the control groups indicates a greater prefrontal activity (dark shading) in t... by Nathan Weisz (3118)

AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature by Melissa Davis (3522224)

“…AR-negative patients have a (66.60; 95% CI, 32–146) odds ratio of being basal-like compared to other PAM50 subtypes, and this is associated with an increased time to progression and decreased overall survival. …”

FASN was not altered in fasting in mice with reduced myocardial PPARα. by Natasha Fillmore (322163)

Viability of <i>L</i>. <i>intracellularis</i>. by Huan W. Yang (19746645)

Scaffold production. by Fabian Westhauser (5314436)

Analysis of amino acid levels. by Dawn B. Lammert (21175128)

Reduction in myocardial PPARα prevents cardiac triglyceride accumulation. by Natasha Fillmore (322163)

Reduced cell viability in Dkp23- and Vaccine-infected PK-15 cells. by Huan W. Yang (19746645)

Control or fasted mice with reduced myocardial PPARα do not have elevated levels of protein oxidation. by Natasha Fillmore (322163)

Regulation of NF-κB target genes. by Huan W. Yang (19746645)

Geographic and topical distribution of the technology adoption evidence. by Aslihan Arslan (9393548)

Potential Interest in Circulating miR-BART17-5p As a Post-Treatment Biomarker for Prediction of Recurrence in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma by Nobuyuki Hirai (3185838)

“…<div><p>Objectives</p><p>Epstein-Barr virus (EBV)-related micoRNAs (miRNAs), BamHI-A rightward transcripts (BART)-miRNAs, are released in a stable form from viable cells, which are abundant in patients with EBV-positive nasopharyngeal carcinoma (NPC). We estimated copy numbers of circulating miR-BART2-5p, miR-BART17-5p, and miR-BART18-5p as well as BamHI-W DNA as biomarkers.…”

Fig 4 - by Esther L. German (14515653)

Reduction in myocardial PPARα mice lowers cardiac Plin2. by Natasha Fillmore (322163)

Placebo test: Alternate DVs. by Vivek Astvansh (14310090)

“…In a local regression discontinuity (RD) analysis, firms that narrowly pass the 50% threshold show a significant decrease in REM, relative to their peers that narrowly fail. …”

Local RD analysis. by Vivek Astvansh (14310090)

“…In a local regression discontinuity (RD) analysis, firms that narrowly pass the 50% threshold show a significant decrease in REM, relative to their peers that narrowly fail. …”

External validity: Global RD analysis. by Vivek Astvansh (14310090)

“…In a local regression discontinuity (RD) analysis, firms that narrowly pass the 50% threshold show a significant decrease in REM, relative to their peers that narrowly fail. …”

Channels of REM. by Vivek Astvansh (14310090)

“…In a local regression discontinuity (RD) analysis, firms that narrowly pass the 50% threshold show a significant decrease in REM, relative to their peers that narrowly fail. …”

Local RD: RTW legislation. by Vivek Astvansh (14310090)

“…In a local regression discontinuity (RD) analysis, firms that narrowly pass the 50% threshold show a significant decrease in REM, relative to their peers that narrowly fail. …”

Summary statistics. by Vivek Astvansh (14310090)

“…In a local regression discontinuity (RD) analysis, firms that narrowly pass the 50% threshold show a significant decrease in REM, relative to their peers that narrowly fail. …”